Leishmaniasis is a tropical disease caused by protozoa belonging to the group of Leishmania species. Visceral leishmaniasis, diffuse cutaneous leishmaniasis, and atypical forms of cutaneous leishmaniasis are common in acquiring HIV. We report a case of atypical cutaneous leishmaniasis (CL) in a person living with HIV.
EzraNOchoaMTCraftN. Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis2010; 2(3): 248–257.
2.
CruzINietoJMorenoJ, et al.Leishmania/HIV co-infections in the second decade. Indian J Med Res2006; 123(3): 357–388.
3.
DaoudiMBoussaaSEchchakeryM, et al.Risk mapping of human HIV-Leishmaniasis co-infection in Morocco. Heliyon2019; 5(9): e02419.
4.
CossartCLe MoalGGarciaM, et al.Manifestations cutanées inhabituelles au cours d’une leishmaniose viscérale associée au VIH [Uncommon cutaneous presentation of visceral Leishmaniasis associated with HIV]. Ann Dermatol Venereol2016; 143(12): 841–845.
5.
BainsAVedantDGuptaP, et al.Unusual presentation of mucocutaneous leishmaniasis in HIV-infected patient. Indian J Sex Transm Dis AIDS2016; 37(2): 193–196.
6.
SoughiMArdigoMBoughalebS, et al.Atypical cutaneous leishmaniasis: contribution of confocal microscopy. JAAD Case Rep2023; 44: 91–93.
7.
NissapatornVSawangjaroenN. Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. Indian J Med Res2011; 134(6): 878–897.
8.
EchchakeryMNietoJBoussaaS, et al.Asymptomatic carriers of Leishmania infantum in patients infected with human immunodeficiency virus (HIV) in Morocco. Parasitol Res2018; 117(4): 1237–1244.
9.
SoughiMSamiraRElloudiS, et al.An atypical cutaneous manifestation of visceral leishmaniasis in an HIV patient. Int J Dermatol2025; 64(3): 592–593.
10.
MehtaVBalachandranCRaoR, et al.Diffuse cutaneous leishmaniasis in HIV. Dermatol Online J2009; 15(4): 9.
11.
BeckerY. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis. Virus Genes2004; 28(1): 5–18.
12.
ShelburneSAVisnegarwalaFDarcourtJ, et al.Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS2005; 19(4): 399–406.
13.
KassardjianAAYimKMRabiS, et al.Diffuse cutaneous leishmaniasis and HIV co-infection: a case report and review of the literature. J Cutan Pathol2021; 48(6): 802–806.
14.
BadaróRGonçalvesLOGoisLL, et al.Leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients: a literature review. J Int Assoc Provid AIDS Care2015; 14(5): 402–407.
